Comparable adverse events––including increased alanine transaminase (ALT), hyperbilirubinemia, and abnormal liver function tests––were also reported in patients with PBC, albeit with low incidence rates [25,26]. This evidence concerns the gene GPT and primary biliary cholangitis.